Aa
MedHelp.org will cease operations on May 31, 2024. It has been our pleasure to join you on your health journey for the past 30 years. For more info, click here.
Aa
A
A
A
Close
Avatar universal

Thyroid Biopsy

According to this do you think the  cancer was contained to the thyroid gland or has spread?

Biopsy Report

CD3: neoplastic cellular infiltrates negative ( background reactive T-cells positive)
CD5: neoplastic cellular infiltrates negative ( background reactive T-cells positive)
MUM-1: subset (about 80%) of neoplastic cellular infiltrates positive
BCL-2: subset of neoplastic cellular infiltrates positive
BCL-6: neoplastic cellular infiltrates negative
BCL-10: neoplastic cellular infiltrates negative
CD20: neoplastic cellular infiltrates strongly positive
Ki67: 90% neoplastic cellular infiltrates positive
Pan-cytokeration: neoplastic cellular infiltrates negative (background follicular cells

positive)
CAM 5.2: neoplastic cellular infiltrates negative (background follicular cells positive)

Final Diagnosis:
Thyroid Gland
1. Diffuse Large B-Cell Lymphoma
2. Hurthle Cell Change
7 Responses
Sort by: Helpful Oldest Newest
1081992 tn?1389903637
COMMUNITY LEADER
that's great news, arkie. That just goes to show, you can never know when things can turn out well. Good luck at the onc today.
Helpful - 0
Avatar universal
Got the results of the PET. Nothing has spread. Only shows some residual in the neck area. Praise the Lord! Off to see the oncologist on Friday....
Thanks to everyone!
Helpful - 0
Avatar universal
Thanks for the response. Will be going for the PET Friday.
Helpful - 0
1081992 tn?1389903637
COMMUNITY LEADER
Hi, arkie. (Sometimes people do post homework on sites like this.)

In general, DLBCL is aggressive - and therefore more prone to spread.

What you want to know is how aggressive is this particular DLBCL. Offhand, I can say it's very complicated and particular to the type of lymphoma, and then to any subtype. People with the "germinal-center" subtype of DLBCL do better.

Here's an example of the complexity:
http://pleiad.umdnj.edu/~dweiss/diffuse_large/diffuse_large.html

Note very well that "there is some controversy" to using these markers.

Note even more so that I am just guessing as a complete amateur. But that page (it's undated so is this current knowledge?) says: "DLBCLs that express germinal center markers CD10 and/or Bcl-6 tend to have a better prognosis than those that express activated B-cell markers MUM1/IRF4 and/or CD138."

But the report you post says CD10 negative and BCL-6 negative, and MUM1 positive. So unfortunately it looks like the non-germinal center subtype.

Then "In the non-germinal center group, expression of Bcl-2 and cyclin D2 are adverse predictors" and the report does say BCL-2 positive.

I recall from the past that high Ki-67 is also not good.

Then again this seems to be DLBCL that started in the thyroid which is rare, so maybe all of this doesn't apply. Everything I say is just guesswork.

I'd get a copy of the PET report rather than wait for a doc appt to have it explained. If nothing lights up then that can set your mind at ease.

It's also true in general that more aggressive lymphomas respond better to treatment, precisely because they are more active. Imagine a room being filled with poison gas: anyone who is running in place would get poisoned quicker and more thoroughly than someone resting. So it's often similar with cancer cells.

Good luck.
Helpful - 0
Avatar universal
My friend had thyroid surgery on the 6th and this was the results from the biopsy. She will be getting a pet scan Friday. I was doing some research on the report and wondering if you could tell if it had spread from the biopsy.
Helpful - 0
Avatar universal
No.
Helpful - 0
907672 tn?1381025723
Hi arkie13,

Is this something you are doing for school?  
Helpful - 0

You are reading content posted in the Leukemia and Lymphoma Community

Top Leukemia & Lymphoma Answerers
1081992 tn?1389903637
PA
Learn About Top Answerers
Popular Resources
An interview with the co-discoverer of one of the biggest breakthroughs in cancer research
From causes to treatment options, get answers to your questions about CML, a type of blood cancer
New drug options on the horizon may make CML, a type of blood cancer, one of the few success stories in cancer treatment
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.